XML 39 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2021
Summary of Significant Accounting Policies  
Schedule of cash and cash equivalents and restricted cash

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that equate to the amount reported in the consolidated statement of cash flows as of December 31, 2021, December 31, 2020 and December 31, 2019 (in thousands):

Year ended

December 31,

2021

2020

2019

Cash and cash equivalents

$

100,708

$

96,596

$

62,430

Restricted cash

9,416

9,566

9,326

Cash, cash equivalents and restricted cash in the consolidated statement of cash flows

$

110,124

$

106,162

$

71,756

Schedule of the Company's net income (loss) per share

The Company’s computation of net (loss) income per share is as follows (in thousands, except per share amounts):

As of

December 31,

2021

2020

2019

Numerator:

Net income (loss) - basic

$

(49,593)

$

(120,348)

$

15,424

Denominator:

Weighted average number of common shares outstanding - basic

46,423

44,497

37,355

Common stock equivalents from outstanding common stock options

-

-

3,495

Common stock equivalents for ESPP

-

-

25

Common stock equivalents from unvested restricted stock units

-

-

270

Weighted average number of common shares outstanding - diluted

46,423

44,497

41,145

Basic net (loss) income per share

$

(1.07)

$

(2.70)

$

0.41

Diluted net (loss) income per share

$

(1.07)

$

(2.70)

$

0.37

Schedule of potentially dilutive securities not included in the calculation of diluted net loss per share attributable to common stockholders

Potentially dilutive securities not included in the calculation of diluted net (loss) income per share because to do so would be anti-dilutive were as follows (weighted outstanding common stock equivalent shares, in thousands):

As of

 

December 31,

 

2021

2020

2019

 

Convertible senior notes

5,125

Stock options outstanding

    

2,951

    

4,399

    

3,616

Unvested restricted stock units

740

526

365

Employee stock purchase plan

11

 

15

 

26

8,827

 

4,940

 

4,007